During the past decade, MD Anderson Regional Care Center-Katy conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson Regional Care Center-Katy" #1 sponsor was "M.D. Anderson Cancer Center" with 7 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson Regional Care Center-Katy" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson Regional Care Center-Katy" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (3 trials), "Fallopian Tube Serous Adenocarcinoma" (3 trials) and "Ovarian Clear Cell Adenocarcinoma" (3 trials). Many other conditions were trialed in "MD Anderson Regional Care Center-Katy" in a lesser frequency.

Most popular intervention types in "MD Anderson Regional Care Center-Katy" are "Drug" (16 trials), "Other" (14 trials), "Biological" (5 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (4 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson Regional Care Center-Katy" are 11 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson Regional Care Center-Katy". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in MD Anderson Regional Care Center-Katy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson Regional Care Center-Katy, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".